The inspection concluded with the issuance of a Form 483 with seventeen observations. "We are committed to addressing the concerns raised by the U.S. FDA expeditiously", the company said in a filing.
It further added, "the Company does not believe that the 483 letter will have an impact on the existing revenues from operations of this facility."
At around 10:22 AM, Lupin Ltd is currently trading at Rs688.80 per share up by Rs0.7 or 0.1% from its previous closing of Rs688.10 per share on the BSE.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.